Norris Medicines Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|
| Revenue | 2.77 | 1.11 | 1.27 |
| Operating Expense | 2.65 | 1.13 | 1.41 |
| Net Profit | -0.23 | -0.28 | -0.36 |
| Net Profit Margin | -8.30 | -25.23 | -28.35 |
| Earning Per Share | -0.23 | -0.28 | -0.36 |
| EBIDTA | 0.06 | -0.03 | -0.15 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Mar 2025 |
|---|---|
| Revenue | 2.77 |
| Operating Expense | 2.65 |
| Net Profit | -0.23 |
| Net Profit Margin | -8.30 |
| Earning Per Share | -0.23 |
| EBIDTA | 0.06 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 5.64 | 8.36 | 9.44 |
| Operating Expenses Annual | 5.82 | 7.44 | 9.51 |
| Operating Profit Annual | -0.16 | 0.94 | -0.05 |
| Interest Annual | 0.37 | 1.50 | 1.48 |
| Depreciation | 0.57 | 0.63 | 0.66 |
| Net Profit Annual | -1.19 | -1.75 | -3.26 |
| Tax Annual | 0.09 | 0.56 | 1.08 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 5.64 |
| Operating Expenses Annual | 5.82 |
| Operating Profit Annual | -0.16 |
| Interest Annual | 0.37 |
| Depreciation | 0.57 |
| Net Profit Annual | -1.19 |
| Tax Annual | 0.09 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.02 | 0.02 | 0.02 |
| Cash Flow from Operations | 0.17 | 1.20 | -1.01 |
| Cash Flow from Investing | 0.05 | -0.02 | -0.09 |
| Cash Flow from Financing | -0.20 | -1.18 | 1.10 |
| Cash Flow at the End | 0.04 | 0.02 | 0.02 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 0.02 |
| Cash Flow from Operations | 0.17 |
| Cash Flow from Investing | 0.05 |
| Cash Flow from Financing | -0.20 |
| Cash Flow at the End | 0.04 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | -2.84 | 11.24 | -0.53 |
| PBIT Margin (%) | -12.94 | 3.71 | -7.52 |
| PBT Margin (%) | 21.99 | 1.20 | -2.54 |
| Net PROFIT Margin (%) | -21.10 | -20.93 | -34.53 |
| Return On Networth / Equity (%) | TBA | TBA | TBA |
| Return On Networth /Employed (%) | TBA | TBA | TBA |
| Return On Assets (%) | -14.14 | -18.00 | -35.22 |
| Total Debt / Equity (X) | TBA | TBA | TBA |
| Asset Turnover Ratio (%) | 0.67 | 0.86 | 1.02 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | -2.84 |
| PBIT Margin (%) | -12.94 |
| PBT Margin (%) | 21.99 |
| Net PROFIT Margin (%) | -21.10 |
| Return On Networth / Equity (%) | TBA |
| Return On Networth /Employed (%) | TBA |
| Return On Assets (%) | -14.14 |
| Total Debt / Equity (X) | TBA |
| Asset Turnover Ratio (%) | 0.67 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 5.79 | 6.47 | 7.07 |
| Total Current Assets Annual | 6.14 | 4.92 | 4.27 |
| Non Current Assets Annual | 8.04 | 8.77 | 9.92 |
| Total Shareholders Funds Annual | -13.63 | -12.44 | -10.69 |
| Total Assets Annual | 14.19 | 13.69 | 14.19 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 5.79 |
| Total Current Assets Annual | 6.14 |
| Non Current Assets Annual | 8.04 |
| Total Shareholders Funds Annual | -13.63 |
| Total Assets Annual | 14.19 |
No Data Availabe
